Why Are Prior Authorization Denials Spiking in Wound Care?
Summary: February 2026 blog post examines the sharp rise in prior authorization (PA) denials for wound care treatments (advanced dressings, NPWT, biologics, debridement). Causes: Payer scrutiny (Medicare Advantage, commercial plans), incomplete documentation (medical necessity, failed conservative care proof), evolving LCDs, and administrative burden. Impacts: Delayed treatment, revenue loss, patient outcomes affected. Solutions: Proactive PA submission checklists, detailed clinical notes/photos, appeals training, payer-specific templates, and outsourcing to specialized RCM services. Urges providers to stay updated on policy shifts and advocate for streamlined processes in chronic wound care.
Key Highlights:
- Rising denials driven by payer policies and documentation gaps
- High-impact areas: Biologics, NPWT, cellular products
- Strategies: Checklists, appeals, RCM support
- Relevance: Critical for access to advanced wound therapies
Keywords: prior authorization, wound care denials, reimbursement challenges, advanced wound therapy